Matthew Winton insider trades

Open-market stock purchases and sales by Matthew Winton, Chief Commercial and Business at CervoMed Inc, from SEC Form 4 filings since Apr 3, 2023.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -63%.

Recent trades

DateStockTradeValue
Feb 11, 2026CRVO CervoMed IncBought (not open market)—
Nov 18, 2025CRVO CervoMed IncBought$11.9K
Nov 17, 2025CRVO CervoMed IncBought$29.5K
Nov 14, 2025CRVO CervoMed IncBought$75.7K
Oct 6, 2025CRVO CervoMed IncBought (not open market)—

Companies traded

  • CRVO CervoMed Inc: 3 buys, last Feb 11, 2026
  • INZY Inozyme Pharma, Inc: other filings, last Jul 1, 2025

Get free alerts when Matthew Winton files a new trade →